Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
5.86
+0.01 (0.17%)
Nov 5, 2024, 11:14 AM EST - Market open
Relay Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Relay Therapeutics stock have an average target of 20.75, with a low estimate of 16 and a high estimate of 28. The average target predicts an increase of 254.10% from the current stock price of 5.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RLAY stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 5 | 5 |
| Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +224.23% | Oct 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +258.36% | Sep 17, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +377.82% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $19 | Strong Buy | Maintains | $18 → $19 | +224.23% | Sep 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +309.56% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
10.36M
from 25.55M
Decreased by -59.44%
Revenue Next Year
675.98K
from 10.36M
Decreased by -93.48%
EPS This Year
-2.90
from -2.79
EPS Next Year
-3.20
from -2.90
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.6M | 6.4M | 81.1M | ||
| Avg | 10.4M | 675,985 | 16.8M | ||
| Low | 9.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -54.7% | -38.3% | 11,893.0% | ||
| Avg | -59.4% | -93.5% | 2,384.8% | ||
| Low | -61.6% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.78 | -2.75 | -2.64 | ||
| Avg | -2.90 | -3.20 | -3.18 | ||
| Low | -2.90 | -3.37 | -3.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.